Prognostic impact of MRD after induction therapy by flow cytometry in 306 AML patients.
Allogeneic transplantation is better than autologous in patients with MRD > 0.1%.
MRD has special interest in the intermediate cytogenetic group.
Scoring system based on MRD and cytogenetics for the prognostic stratification.